Close
4
Promoted Content
Promoted Content

Company profile for Oncopeptides AB

Client EmailClient Virtual Booth
ONCOPEPTIDES AB
  • Connect with Us...

PharmaCompass
About the Company
Oncopeptides is a pharmaceutical company focused on the development of therapies for difficult-to-treat hematological diseases. The company is focusing on the development of the lead product candidate melflufen in multiple myeloma. Melflufen is a novel peptide-drug conjugate that rapidly delivers a cytotoxic payload into tumor cells. Melflufen is currently being tested in four clinical studies including the pivotal phase 2 HO...
Oncopeptides is a pharmaceutical company focused on the development of therapies for difficult-to-treat hematological diseases. The company is focusing on the development of the lead product candidate melflufen in multiple myeloma. Melflufen is a novel peptide-drug conjugate that rapidly delivers a cytotoxic payload into tumor cells. Melflufen is currently being tested in four clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study, the phase 1/2 combination study ANCHOR and the phase 2 Study BRIDGE.
Upgrade the company profile

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Oncopeptides AB
Sweden Flag
Country
Country
SWEDEN
Address
Address
Luntmakargatan 46, vån 7 SE-111 37 Stockholm
Telephone
Telephone
+46 8 615 20 40
Twitter
Twitter
Client Virtual Booth

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Learn More About